Candida albicans migrates itself from the vagina to the uterus and ovaries in estrogenized mice
Brazilian Journal of Microbiology · 2025
DOI: 10.1007/s42770-024-01602-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brazilian Journal of Microbiology, 2025. Verfasst von Valeria Mosca und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Analysis and Biomedicine, Laboratory of Medical Mycology, State University of Maringá, Maringá, Paraná, Brazil. Hauptthemen laut MEDLINE: Candida albicans, Vagina, Ovary, Candidiasis, Vulvovaginal. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Instituto Nacional de Ciência e Tecnologia da Criosfera.
Abstract (Originalsprache)
Vulvovaginal candidiasis (VVC) represents the second cause of vaginal infections in childbearing-age women. It mainly affects the vulva and vagina; however, other organs can be compromised, with consequences that are not well known yet. To evaluate the ability of Candida albicans, inoculated into the vaginal lumen of mice, to migrate to the uterus and ovaries. Female Balb/c mice, 6 weeks old, were estrogenized and infected intravaginally with 1 × 106 CFU/ml of C. albicans for the dual objectives of histopathological evaluation and fungal burden quantification in the vaginal, uterus, and ovary tissues, on days 1, 3, and 5 post-infection. Estrogenized and infected mice presented vaginal exudate and an edematous and erythematous uterus. Vaginal histopathological analysis showed intense desquamation, keratinization, fungal structures, and an inflammatory reaction one day after infection. In the uterus, an inflammatory response and a few fungi from the third day onwards were observed. Similarly, the ovary showed the same changes, but at a lower intensity. A high fungal burden was detected in the vaginal tissue from the first day, reaching nearly 6 log CFU/g on the fifth day. C. albicans inoculated into the vaginal lumen of estrogenized mice was able to invade the vaginal tissue one-day post-infection and was detected in the uterus and ovaries within three days.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Analysis and Biomedicine, Laboratory of Medical Mycology, State University of Maringá, Maringá, Paraná, Brazil.
- Department of Basic Health Sciences, Laboratory of Pathology, State University of Maringá, Maringá, Paraná, Brazil.
- Department of Clinical Analysis and Biomedicine, Laboratory of Medical Mycology, State University of Maringá, Maringá, Paraná, Brazil. tiesvidzinski@uem.br.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Instituto Nacional de Ciência e Tecnologia da Criosfera
Zitieren
APA
Mosca, V., Arita, G. S., Sakita, K. M., Rodrigues-Vendramini, F. A. V., Faria, D. R., Conrado, P. C. V., Galinari, C. B., Kioshima, É. S., Becker, T. C. A., de Souza Bonfim-Mendonça, P., & Svidzinski, T. I. E. (2025). Candida albicans migrates itself from the vagina to the uterus and ovaries in estrogenized mice. Brazilian Journal of Microbiology. https://doi.org/10.1007/s42770-024-01602-9
Vancouver
Mosca V, Arita GS, Sakita KM, Rodrigues-Vendramini FAV, Faria DR, Conrado PCV, et al. Candida albicans migrates itself from the vagina to the uterus and ovaries in estrogenized mice. Brazilian Journal of Microbiology. 2025. doi:10.1007/s42770-024-01602-9
BibTeX
@article{Mosca2025,
author = {Mosca, Valeria and Arita, Glaucia Sayuri and Sakita, Karina Mayumi and Rodrigues-Vendramini, Franciele Abigail Vilugron and Faria, Daniella Renata and Conrado, Pollyanna Cristina Vincenzi and Galinari, Camila Barros and Kioshima, Érika Seki and Becker, Tania Cristina Alexandrino and de Souza Bonfim-Mendonça, Patrícia and Svidzinski, Terezinha Inez Estivalet},
title = {Candida albicans migrates itself from the vagina to the uterus and ovaries in estrogenized mice},
journal = {Brazilian Journal of Microbiology},
year = {2025},
doi = {10.1007/s42770-024-01602-9}
}
EUVIMED